Avrobio Inc reported -29418000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Akebia Therapeutics AKBA:US $ -58.49M 7.66M
Alnylam Pharmaceuticals ALNY:US $ -146.73M 47.83M
Applied Genetic Technologies AGTC:US $ -13.58M 4.86M
Bluebird Bio BLUE:US $ -120.35M 15.32M
Epizyme EPZM:US $ -50926000 360K
Gilead Sciences GILD:US $ 197M 743M
Intercept Pharmaceuticals ICPT:US $ -10.27M 10.59M
Karyopharm Therapeutics KPTI:US $ -34586000 81.55M
Macrogenics MGNX:US $ -66638000 8.4M
Pfizer PFE:US $ 9873M 5297M
Sangamo Biosciences SGMO:US $ -45.26M 5.36M
Sarepta Therapeutics SRPT:US $ -86.88M 18.93M
Takeda 4502:JP Y -1619M 118103M